WO2012090043A8 - Novel solid state forms of azilsartan medoxomil and preparation thereof - Google Patents
Novel solid state forms of azilsartan medoxomil and preparation thereof Download PDFInfo
- Publication number
- WO2012090043A8 WO2012090043A8 PCT/IB2011/003055 IB2011003055W WO2012090043A8 WO 2012090043 A8 WO2012090043 A8 WO 2012090043A8 IB 2011003055 W IB2011003055 W IB 2011003055W WO 2012090043 A8 WO2012090043 A8 WO 2012090043A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solid state
- preparation
- azilsartan medoxomil
- state forms
- novel solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention provides novel solid state forms of azilsartan medoxomil and process for the preparation thereof. The solid state forms of the present invention includes crystalline forms viz. J2, J3, J4, J5, J6, J7, J8, J9 and amorphous forms of azilsartan medoxomil. Further, it relates to the pharmaceutical composition and use of the said formulation to treat the conditions in a subject in need thereof.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3155DE2010 | 2010-12-29 | ||
IN3155/DEL/2010 | 2010-12-29 | ||
IN316DE2011 | 2011-02-08 | ||
IN316/DEL/2011 | 2011-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012090043A1 WO2012090043A1 (en) | 2012-07-05 |
WO2012090043A8 true WO2012090043A8 (en) | 2012-09-13 |
Family
ID=45540893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/003055 WO2012090043A1 (en) | 2010-12-29 | 2011-12-16 | Novel solid state forms of azilsartan medoxomil and preparation thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012090043A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102323280A (en) * | 2011-05-11 | 2012-01-18 | 浙江长生鸟珍珠生物科技有限公司 | Quality detection methods of pearl powder and application thereof |
WO2013042066A1 (en) * | 2011-09-20 | 2013-03-28 | Ranbaxy Laboratories Limited | Process for the preparation of azilsartan medoxomil |
US9403811B2 (en) | 2012-01-14 | 2016-08-02 | Sunshine Lake Pharma Co., Ltd. | Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof |
WO2013124748A1 (en) * | 2012-02-20 | 2013-08-29 | Alembic Pharmaceuticals Limited | Novel polymorphs of azilsartan medoxomil potassium |
CZ2012274A3 (en) * | 2012-04-19 | 2013-10-30 | Zentiva, K.S. | Process for preparing extremely pure potassium salt of azilsartan medoxomil |
WO2013186792A2 (en) * | 2012-06-11 | 2013-12-19 | Msn Laboratories Limited | Process for the preparation of (5-methyl-2-oxo-l,3-dioxoi-4-vl)methvl 2- ethoxv-l-{[2'-(5-oxo-4,5-dihvdro-l,2,4-oxadiazol-3-vl)biphenyi-4-vl]methyl}- lh-benzimidazole-7-carboxyiate and its salts |
EP2870151A4 (en) * | 2012-07-09 | 2016-03-23 | Hetero Research Foundation | Novel polymorphs of azilsartan |
WO2014020381A1 (en) * | 2012-08-01 | 2014-02-06 | Alembic Pharmaceuticals Limited | Novel crystalline form of azilsartan medoxomil potassium |
CA2890961A1 (en) * | 2012-08-27 | 2014-03-06 | Hetero Research Foundation | Novel polymorphs of azilsartan medoxomil |
WO2014049512A2 (en) | 2012-09-26 | 2014-04-03 | Lupin Limited | Novel process for preparation of azilsartan medoxomil |
CZ305318B6 (en) * | 2012-09-26 | 2015-07-29 | Zentiva, K.S. | Process for preparing extremely pure azilsartan medoxomil potassium salt |
CN103709154B (en) * | 2012-09-28 | 2016-06-15 | 武汉朗来科技发展有限公司 | Benzimidizole derivatives and preparation method thereof and medical usage |
CN103880829B (en) * | 2012-12-21 | 2016-07-06 | 上海医药工业研究院 | A kind of Azilsartan crystal and its production and use |
CN103910720A (en) * | 2013-01-07 | 2014-07-09 | 广东东阳光药业有限公司 | Novel crystal form of azilsartan medoxomil and preparation method thereof |
CN105153141B (en) * | 2013-02-04 | 2018-09-25 | 武汉朗来科技发展有限公司 | Benzimidizole derivatives and preparation method thereof and medical usage |
CN104774196B (en) * | 2014-01-09 | 2017-11-10 | 武汉朗来科技发展有限公司 | A kind of preparation method of benzimidizole derivatives |
CN104557899B (en) * | 2014-11-17 | 2018-05-22 | 江苏中邦制药有限公司 | A kind of preparation method of Azilsartan I crystal crystal |
WO2016145622A1 (en) | 2015-03-18 | 2016-09-22 | 武汉朗来科技发展有限公司 | Benzimidazole derivatives, preparation method therefor and medicinal use thereof |
CN106032378B (en) * | 2015-03-20 | 2019-10-25 | 武汉启瑞药业有限公司 | New A RB compound and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157584B2 (en) * | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
-
2011
- 2011-12-16 WO PCT/IB2011/003055 patent/WO2012090043A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012090043A1 (en) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012090043A8 (en) | Novel solid state forms of azilsartan medoxomil and preparation thereof | |
WO2012068441A3 (en) | Intedanib salts and solid state forms thereof | |
WO2011150156A3 (en) | Heteroaryl compounds and methods of use thereof | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2011121418A9 (en) | 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists | |
WO2010090860A3 (en) | Methods and compositions for treating bacterial infection | |
WO2011041694A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
WO2010132882A3 (en) | Sublingual dexmedetomidine compositions and methods of use thereof | |
WO2011057262A3 (en) | Treatment of infections with tp receptor antagonists | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2012156998A3 (en) | Amorphous mirabegron and processes for crystal forms of mirabegron | |
WO2009019303A3 (en) | A process for the preparation or purification of olmesartan medoxomil | |
WO2012085927A3 (en) | Tadalafil compositions | |
CL2013000785A1 (en) | Compounds 3-fluoro-4- (5-fluoro-6- (4- (3- (2-fluoropropan-2-yl) -1,2,4-oxadiazol-5-yl) piperidin-1-yl) pyrimidin- 4-ylamino) (- n, n-dimethylbenzamide or -n-methylbenzamide or -benzamide); pharmaceutical composition; Preparation method; pharmaceutical product; treatment method; use to treat a neurological disorder, among others. | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2008098978A3 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
WO2010005565A3 (en) | Method of treating glycogen storage disease | |
WO2008137134A3 (en) | Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide | |
WO2011080254A3 (en) | Fungicide hydroximoyl-heterocycles derivatives | |
WO2010129636A3 (en) | Lenalidomide polymorph | |
WO2011007368A3 (en) | An improved process for preparation of olmesartan | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2012148148A3 (en) | Novel zinc azide complex and a process for preparing tetrazole derivatives using the same | |
WO2013088384A3 (en) | Solid state forms of azilsartan and azilsartan medoxomil monopotassium and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11813689 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11813689 Country of ref document: EP Kind code of ref document: A1 |